Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EZM0414 |
Synonyms | |
Therapy Description |
EZM0414 inhibits SETD2, potentially reducing tumor growth (PMID: 35859865). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EZM0414 | EZM-0414|EZM 0414 | EZM0414 inhibits SETD2, potentially reducing tumor growth (PMID: 35859865). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05121103 | Phase I | EZM0414 | A Study in Subjects With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Terminated | USA | 0 |